ABB-backed surgical robotics developer CMR raised the cash at a reported valuation in excess of $1.2bn and has now secured $386m in total.

Pfizer spinoff Springworks, which also counts GlaxoSmithKline as an investor, secured $162m in an initial public offering that followed $228m of funding.

Immonogenomics blood test developer OncoCell, a Harvard Medical School spinout, has increased its total funding to $30m.

The Fosun-backed stroke-prevention technology developer received $14.1m in a round led by Hidea Venture Capital that will fund clinical testing for its devices.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Vision Fund sold 4.9 million shares in cancer test developer Guardant Health at more than four times their price in the company's 2018 IPO.

TCV has led a $200m round for online pharmacy Capsule, increasing the Virgin-backed company's total funding to $270m.

Woodford Investment Management is reportedly poised for another beating as its portfolio company BenevolentAI seeks funding from Temasek at half of its previous $2bn valuation.

Max Planck Foundation joined the EIF and AWS as a limited partner in university-focused drug discovery fund Khan Technology Transfer Fund I.

Shin Nippon's migraine treatment spinoff, Satsuma Pharmaceuticals, floated above its range to raise $82.5m in an offering that follows $86m of funding.